SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021)

被引：4

作者：

Martinez-Garcia, Maria ^{[1
,2
]}

Servitja Tormo, Sonia ^{[1
]}

Vilarino Quintela, Noelia ^{[3
]}

Arance Fernandez, Ana ^{[4
]}

Berrocal Jaime, Alfonso ^{[5
]}

Cantos Sanchez de Ibarguen, Blanca ^{[6
]}

Del Barco Berron, Sonia ^{[7
]}

Garcia Campelo, Rosario ^{[8
]}

Girones Sarrio, Regina ^{[9
]}

Manuel Sepulveda-Sanchez, Juan ^{[10
]}

机构：

[1] Hosp Mar, Dept Med Oncol, Barcelona, Spain

[2] CIOCC HM Delfos, Barcelona, Spain

[3] Inst Catala Oncol L Hosp, Dept Med Oncol, Barcelona, Spain

[4] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[5] Consorcio Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain

[6] Hosp Univ Puerta Hierro Majadahonda, Dept Med Oncol, Madrid, Spain

[7] Hosp Univ Dr Josep Trueta, Dept Med Oncol, ICO, Girona, Spain

[8] Complexo Hosp Univ A Coruna CHUAC, Dept Med Oncol, La Coruna, Spain

[9] Hosp Univ & Politecn La Fe, Dept Med Oncol, Valencia, Spain

[10] Hosp Univ, Dept Med Oncol, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2022年 / 24卷 / 04期

关键词：

Brain metastasis; Blood-brain barrier; Targeted therapies; Immunotherapy; Guidelines; CELL LUNG-CANCER; NEGATIVE BREAST-CANCER; OPEN-LABEL; MUTANT MELANOMA; FOLLOW-UP; CRIZOTINIB; CHEMOTHERAPY; MULTICENTER; SURVIVAL; DABRAFENIB;

D O I：

10.1007/s12094-022-02803-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Central nervous system (CNS) dissemination is a severe complication in cancer and a leading cause of cancer-related mortality. Brain metastases (BMs) are the most common types of malignant intracranial tumors and are reported in approximately 25% of patients with metastatic cancers. The recent increase in incidence of BMs is due to several factors including better diagnostic assessments and the development of improved systemic therapies that have lower activity on the CNS. However, newer systemic therapies are being developed that can cross the blood-brain barrier giving us additional tools to treat BMs. The guidelines presented here focus on the efficacy of new targeted systemic therapies and immunotherapies on CNS BMs from breast, melanoma, and lung cancers.

引用

页码：703 / 711

页数：9

共 50 条

[31] Stereotactic radiosurgery for small brain metastases and implications regarding management with systemic therapy alone
Trifiletti, Daniel M.
Hill, Colin
Cohen-Inbar, Or
Xu, Zhiyuan
Sheehan, Jason P.
JOURNAL OF NEURO-ONCOLOGY, 2017, 134 (02) : 289 - 296
[32] EGFR Exon 19 Deletion Mutations and Systemic/Central Nervous System Miliary Metastasis: Clinical Correlations and Response to Therapy
Poonia, Seerat
Berge, Eamon M.
Aisner, Dara L.
Damek, Denise
Doebele, Robert C.
CLINICAL LUNG CANCER, 2014, 15 (05) : 387 - 389
[33] Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation
Wang, Song-Quan
Yuan, Qing
Zhang, Guang-Tao
Qian, Hai-Peng
Liu, Zhi-Dan
Wang, Jia-Wei
Cai, Hong-Qing
Wan, Jing-Hai
TRANSLATIONAL CANCER RESEARCH, 2022, 11 (01) : 63 - 71
[34] Imaging Recommendations for Diagnosis, Staging, and Management of Central Nervous System Neoplasms in Adults: CNS Metastases
Bhattacharya, Kajari
Mahajan, Abhishek
Mynalli, Soujanya
CANCERS, 2024, 16 (15)
[35] Progress in the Biological Understanding and Management of Breast Cancer-Associated Central Nervous System Metastases
Dawood, Shaheenah
Gonzalez-Angulo, Ana M.
ONCOLOGIST, 2013, 18 (06) : 675 - 684
[36] Central nervous system metastases from HER2 positive breast cancers: what to do in 2021?
Bachelot, Thomas
Bailleux, Caroline
Darlix, Amelie
Jacot, William
BULLETIN DU CANCER, 2021, 108 (11) : S15 - S23
[37] Clinical Outcome of Stereotactic Radiosurgery for Central Nervous System Metastases From Renal Cell Carcinoma
Seastone, D. J.
Elson, P.
Garcia, J. A.
Chao, S. T.
Suh, J. H.
Angelov, L.
Rini, B. I.
CLINICAL GENITOURINARY CANCER, 2014, 12 (02) : 111 - 116
[38] Central nervous system metastases as a cause of the first clinical symptoms of breast cancer - a case report
Ziolkowska, Ewa
Lozynka-Podhrebelna, Diana
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (06): : 318 - 321
[39] Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases
Seoane, J.
De Mattos-Arruda, L.
Le Rhun, E.
Bardelli, A.
Weller, M.
ANNALS OF ONCOLOGY, 2019, 30 (02) : 211 - 218
[40] Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases
Doyle, Danielle M.
Einhorn, Lawrence H.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (05): : 1361 - 1364

← 1 2 3 4 5 →